Saudi Arabia In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Saudi Arabia In Vitro Diagnostics Market Outlook to 2018 -
Clinical Chemistry Genetic Testing, Haematology, Histology
and Cytology, Immuno Chemistry, Infectious Immunology and
Microbiology Culture
Report Details:
Published:December 2012
No. of Pages: 251
Price: Single User License – US$2500

Saudi Arabia In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing,
Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and
Microbiology Culture

Summary

GlobalData’s new report, “Saudi Arabia In Vitro Diagnostics Market Outlook to 2018 - Clinical
Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious
Immunology and Microbiology Culture” provides key market data on the Saudi Arabia In Vitro
Diagnostics market. The report provides value (USD million), volume (units) and average price
(USD) data for each segment and sub-segment within market categories – Immuno Chemistry,
Clinical Chemistry, Haematology, Infectious Immunology, Histology And Cytology, Microbiology
Culture and Genetic Testing. The report also provides company shares and distribution shares
data for each of the aforementioned market categories. The report is supplemented with global
corporate-level profiles of the key market participants with information on company financials and
pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics market categories – Immuno
Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Histology And Cytology,
Microbiology Culture and Genetic Testing.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for

each of the segments and sub-segments within market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the Saudi Arabia In Vitro
Diagnostics market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott
Laboratories, Beckman Coulter, Inc., bioMerieux S.A., Becton, Dickinson and Company and
others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Saudi Arabia In Vitro
Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.

Get your copy of this report @
http://www.reportsnreports.com/reports/213281-saudi-arabia-in-vitro-diagnostics-market-outlook-to-2018-clinical-
chemistry-genetic-testing-haematology-histology-and-cytology-immuno-chemistry-infectious-immunology-and-
microbiology-culture.html

Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 13
2 Introduction 16
2.1 What is This Report About? 16
3 In Vitro Diagnostics In Saudi Arabia 17
3.1 In Vitro Diagnostics, Market Segmentation 17
3.2 In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, 2004-2018 18
3.3 In Vitro Diagnostics Market, Saudi Arabia, Revenue Mix ($m), 2011 20
3.4 In Vitro Diagnostics Market, Saudi Arabia, Category Contribution (%), 2011 21
3.5 In Vitro Diagnostics, Saudi Arabia, Company Share (2010-2011) 28
4 Clinical Chemistry In Saudi Arabia 30
4.1 Clinical Chemistry, Market Segmentation 30
4.2 Clinical Chemistry Market, Saudi Arabia, Revenue Mix ($m), 2011 31
4.3 Clinical Chemistry Market, Saudi Arabia, Segment Contribution (%), 2011 32
4.4 Clinical Chemistry Overall Revenue, (2004-2018) 33

4.4.1 Clinical Chemisty Analyzers, Revenue (2004-2018) 37
4.4.2 Urine Analysis, Revenue (2004-2018) 41
4.5 Clinical Chemistry Distribution Share (2010-2011) 45
4.6 Clinical Chemistry, Saudi Arabia, Company Share (2010-2011) 46
5 Genetic Testing In Saudi Arabia 48
5.1 Genetic Testing, Market Segmentation 48
5.2 Genetic Testing Market, Saudi Arabia, Revenue Mix ($m), 2011 49
5.3 Genetic Testing Market, Saudi Arabia, Segment Contribution (%), 2011 50
5.4 Genetic Testing Overall Revenue, (2004-2018) 51
5.5 Genetic Testing Distribution Share (2010-2011) 55
5.6 Genetic Testing, Saudi Arabia, Company Share (2010-2011) 56
6 Haematology In Saudi Arabia 58
6.1 Haematology Market, Market Segmentation 58
6.2 Haematology Market, Saudi Arabia, Revenue Mix ($m), 2011 59
6.3 Haematology Market, Saudi Arabia, Segment Contribution (%), 2011 60
6.4 Haematology Overall Revenue, (2004-2018) 61
6.4.1 Haematology Reagents, Revenue (2004-2018) 65
6.4.2 Immunohaematology, Revenue (2004-2018) 69
6.4.3 Haemostasis, Revenue (2004-2018) 73
6.4.4 Haematology Rapid Tests, Revenue (2004-2018) 77
6.4.5 Haematology Cell Counters, Revenue (2004-2018) 81
6.5 Haematology Distribution Share (2010-2011) 85
6.6 Haematology, Saudi Arabia, Company Share (2010-2011) 86
7 Histology And Cytology In Saudi Arabia 88
7.1 Histology and Cytology Market, Market Segmentation 88
7.2 Histology And Cytology Market, Saudi Arabia, Revenue Mix ($m), 2011 89
7.3 Histology And Cytology Market, Saudi Arabia, Segment Contribution (%), 2011 90
7.4 Histology And Cytology Overall Revenue, (2004-2018) 91
7.5 Histology And Cytology Distribution Share (2010-2011) 95
7.6 Histology And Cytology, Saudi Arabia, Company Share (2010-2011) 96
8 Immuno Chemistry In Saudi Arabia 98
8.1 Immuno Chemistry Market, Saudi Arabia, Revenue Mix ($m), 2011 98
8.2 Immuno Chemistry Market, Saudi Arabia, Segment Contribution (%), 2011 99
8.3 Immuno Chemistry Overall Revenue, (2004-2018) 100
8.3.1 Disease Specific Immunochemistry, Revenue (2004-2018) 104
8.3.2 Drugs of Abuse / Toxicology, Revenue (2004-2018) 108
8.3.3 Endocrinology Tests, Revenue (2004-2018) 112
8.3.4 Immunochemistry Rapid Tests, Revenue (2004-2018) 116
8.3.5 Therapeutic Drug Monitoring, Revenue (2004-2018) 120
8.3.6 Immunochemistry Analyzers, Revenue (2004-2018) 124
8.4 Immuno Chemistry Distribution Share (2010-2011) 128
8.5 Immuno Chemistry, Saudi Arabia, Company Share (2010-2011) 129

9 Infectious Immunology In Saudi Arabia 131
9.1 Infectious Immunology, Market Segmentation 131
9.2 Infectious Immunology Market, Saudi Arabia, Revenue Mix ($m), 2011 132
9.3 Infectious Immunology Market, Saudi Arabia, Segment Contribution (%), 2011 133
9.4 Infectious Immunology Overall Revenue, (2004-2018) 134
9.4.1 Infectious Immunology Rapid Tests, Revenue (2004-2018) 138
9.5 Infectious Immunology Distribution Share (2010-2011) 142
9.6 Infectious Immunology, Saudi Arabia, Company Share (2010-2011) 143
10 Microbiology Culture In Saudi Arabia 145
10.1 Microbiology Culture, Market Segmentation 145
10.2 Microbiology Culture Market, Saudi Arabia, Revenue Mix ($m), 2011 146
10.3 Microbiology Culture Market, Saudi Arabia, Segment Contribution (%), 2011 147
10.4 Microbiology Culture Overall Revenue, (2004-2018) 148
10.4.1 Microbiology Analyzers, Revenue (2004-2018) 152
10.5 Microbiology Culture Distribution Share (2010-2011) 156
10.6 Microbiology Culture, Saudi Arabia, Company Share (2010-2011) 157
11 Overview of Key Companies in Saudi Arabia In Vitro Diagnostics Market 159
11.1 F. Hoffmann-La Roche Ltd. 159
11.1.1 Company Overview 159
11.1.2 Share in the Saudi Arabia In Vitro Diagnostics Market 159
11.2 Siemens Healthcare 160
11.3 Abbott Laboratories 161
11.4 Beckman Coulter, Inc. 162
11.4.2 Share in the United States In Vitro Diagnostics Market 162
11.5 bioMerieux S.A. 163
11.6 Becton, Dickinson and Company 164
11.7 Ortho-Clinical Diagnostics Inc. 165
11.8 Mindray Medical International Limited 165
11.9 Bio-Rad Laboratories, Inc. 166
11.10 Sysmex Corporation 166

11.11 Qiagen N.V. 167
11.12 Thermo Fisher Scientific Inc. 167
11.13 Grifols, S.A. 168
11.14 Horiba, Ltd. 168
11.15 PerkinElmer, Inc. 169
11.16 Life Technologies Corporation 169
11.17 Phadia AB 170
11.18 DiaSorin S.p.A 170
11.19 Gen-Probe Incorporated 171
11.20 Diagnostica Stago, Inc. 171
11.21 Chembio Diagnostics, Inc. 172
11.22 Alere Inc. 172
11.23 Immucor, Inc. 173
11.24 Hologic, Inc. 173
12 In Vitro Diagnostics Market Pipeline Products 174
12.1 Clinical Chemisty Market Pipeline Products 174
12.2 Immuno Chemistry Market Pipeline Products 177
12.3 Haematology Market Pipeline Products 188
12.4 Infectious Immunology Market Pipeline Products 190
12.5 Microbiology Culture Market Pipeline Products 197
12.6 Histology And Cytology Market Pipeline Products 198
12.7 Genetic Testing Market Pipeline Products 199
13 Financial Deals Landscape 204
13.1 Partnerships 204
13.1.1 Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For
Archimedes Particle Metrology System 204
13.1.2 Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ 205

13.1.3 BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology
Assays 206
13.1.4 CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital
Microscopy Hematology Solutions 207
13.1.5 Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress
Dx Test 208
13.1.6 Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology
209
13.1.7 Life Technologies Enters Into Co-Marketing Agreement With Pathogenica 210
13.1.8 CML HealthCare Enters Into Agreement With MaRS Innovation 211
13.1.9 Castle Biosciences Enters Into Licensing Agreement With Brigham and Women''s Hospital
For Mesothelioma Test 212
13.1.10 Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein
Array Products 213
13.1.11 GeneCentric Diagnostics Enters Into Licensing Agreement With University of North
Carolina 214
13.1.12 NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype
DX Tests 215
13.1.13 Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB
Test 216
13.1.14 SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For
PhenoFluor 217
13.1.15 Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 218
13.1.16 MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test 219
13.1.17 NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
220
13.1.18 Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis 221
13.1.19 Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC
Test 222
13.1.20 One Lambda Enters Into Co-Marketing Agreement With CellTrend 223
13.1.21 Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For
ALK Cancer Biomarker 224
13.1.22 Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 225
13.1.23 Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
226
13.1.24 Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell
Technology 227
13.1.25 Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA 228
13.1.26 Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange
PCR Kit 229
13.1.27 Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo 230
13.1.28 Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For

Pressure Cycling Technology 231
13.1.29 LipoScience Enters Into Licensing Agreement With Cleveland Clinic 232
13.1.30 GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact
Cyclotron And PET Tracer System 233
13.1.31 NexDx Enters Into Licensing Agreement With University of California For Epigenetic
Biomarkers 234
13.1.32 Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 235
14 Appendix 236
14.1 Definitions of Markets Covered in the Report 237
14.1.1 In Vitro Diagnostics 237
14.2 Research Methodology 248
14.3 Secondary Research 248
14.4 Primary Research 249
14.5 Models 249
14.6 Forecasts 250
14.7 Expert Panels 250
14.8 GlobalData Consulting 250
14.9 Currency Conversion 251
14.10 Contact Us 251
14.11 Disclaimer 251

1.1 List of Tables
Table 1: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, 2004-2018 19
Table 2: In Vitro Diagnostics Market, Saudi Arabia, Category Contribution (%), 2011 21
Table 3: In Vitro Diagnostics Market, Saudi Arabia, Cross-Category Analysis, 2004-2018 23
Table 4: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 25
Table 5: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, Forecast,
2011-2018 27
Table 6: In Vitro Diagnostics, Saudi Arabia, Company Share by Revenue ($m), USD Constant,
2010-2011 29
Table 7: Clinical Chemistry Market, Saudi Arabia, Segment Contribution (%), 2011 32
Table 8: Clinical Chemistry, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 34
Table 9: Clinical Chemistry, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 36
Table 10: Clinical Chemisty Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 38
Table 11: Clinical Chemisty Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 40
Table 12: Urine Analysis, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 42

Table 13: Urine Analysis, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 44
Table 14: Clinical Chemistry, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant,
2010-2011 45
Table 15: Clinical Chemistry, Saudi Arabia, Company Share by Revenue ($m), USD Constant,
2010-2011 47
Table 16: Genetic Testing Market, Saudi Arabia, Segment Contribution (%), 2011 50
Table 17: Genetic Testing, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 52
Table 18: Genetic Testing, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 54
Table 19: Genetic Testing, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant,
2010-2011 55
Table 20: Genetic Testing, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-
2011 57
Table 21: Haematology Market, Saudi Arabia, Segment Contribution (%), 2011 60
Table 22: Haematology, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 62
Table 23: Haematology, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 64
Table 24: Haematology Reagents, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 66
Table 25: Haematology Reagents, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 68
Table 26: Immunohaematology, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 70
Table 27: Immunohaematology, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 72
Table 28: Haemostasis, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 74
Table 29: Haemostasis, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 76
Table 30: Haematology Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Table 31: Haematology Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Table 32: Haematology Cell Counters, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Table 33: Haematology Cell Counters, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Table 34: Haematology, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 85

Table 35: Haematology, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-
2011 87
Table 36: Histology And Cytology Market, Saudi Arabia, Segment Contribution (%), 2011 90
Table 37: Histology And Cytology, Saudi Arabia, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 92
Table 38: Histology And Cytology, Saudi Arabia, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 94
Table 39: Histology And Cytology, Saudi Arabia, Distribution Share by Revenue ($m), USD
Constant, 2010-2011 95
Table 40: Histology And Cytology, Saudi Arabia, Company Share by Revenue ($m), USD
Constant, 2010-2011 97
Table 41: Immuno Chemistry Market, Saudi Arabia, Segment Contribution (%), 2011 99
Table 42: Immuno Chemistry, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 101
Table 43: Immuno Chemistry, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 103
Table 44: Disease Specific Immunochemistry, Saudi Arabia, Revenue ($m) USD Constant, by
Sub-Segment, Historic, 2004-2011 105
Table 45: Disease Specific Immunochemistry, Saudi Arabia, Revenue ($m) USD Constant, by
Sub-Segment, Forecast, 2011-2018 107
Table 46: Drugs of Abuse / Toxicology, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Table 47: Drugs of Abuse / Toxicology, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Table 48: Endocrinology Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 113
Table 49: Endocrinology Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 115
Table 50: Immunochemistry Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Table 51: Immunochemistry Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Table 52: Therapeutic Drug Monitoring, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Table 53: Therapeutic Drug Monitoring, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Table 54: Immunochemistry Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Table 55: Immunochemistry Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Table 56: Immuno Chemistry, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant,
2010-2011 128

Table 57: Immuno Chemistry, Saudi Arabia, Company Share by Revenue ($m), USD Constant,
2010-2011 130
Table 58: Infectious Immunology Market, Saudi Arabia, Segment Contribution (%), 2011 133
Table 59: Infectious Immunology, Saudi Arabia, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 135
Table 60: Infectious Immunology, Saudi Arabia, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 137
Table 61: Infectious Immunology Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by
Table 62: Infectious Immunology Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by
Table 63: Infectious Immunology, Saudi Arabia, Distribution Share by Revenue ($m), USD
Constant, 2010-2011 142
Table 64: Infectious Immunology, Saudi Arabia, Company Share by Revenue ($m), USD
Constant, 2010-2011 144
Table 65: Microbiology Culture Market, Saudi Arabia, Segment Contribution (%), 2011 147
Table 66: Microbiology Culture, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 149
Table 67: Microbiology Culture, Saudi Arabia, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 151
Table 68: Microbiology Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 153
Table 69: Microbiology Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 155
Table 70: Microbiology Culture, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant,
2010-2011 156
Table 71: Microbiology Culture, Saudi Arabia, Company Share by Revenue ($m), USD Constant,
2010-2011 158
Table 72: Clinical Chemisty Market Pipeline Products 174
Table 73: Immuno Chemistry Market Pipeline Products 177
Table 74: Haematology Market Pipeline Products 188
Table 75: Infectious Immunology Market Pipeline Products 190
Table 76: Microbiology Culture Market Pipeline Products 197
Table 77: Histology And Cytology Market Pipeline Products 198
Table 78: Genetic Testing Market Pipeline Products 199
Table 79: Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For
Archimedes Particle Metrology System 204
Table 80: Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ 205
Table 81: BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology
Assays 206
Table 82: CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital
Microscopy Hematology Solutions 207

Table 83: Med BioGene Amends Licensing Agreement With Precision Therapeutics For
LungExpress Dx Test 208
Table 84: Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon
Biotechnology 209
Table 85: Life Technologies Enters Into Co-Marketing Agreement With Pathogenica 210
Table 86: CML HealthCare Enters Into Agreement With MaRS Innovation 211
Table 87: Castle Biosciences Enters Into Licensing Agreement With Brigham and Women''s
Hospital For Mesothelioma Test 212
Table 88: Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein
Array Products 213
Table 89: GeneCentric Diagnostics Enters Into Licensing Agreement With University of North
Carolina 214
Table 90: NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For
Oncotype DX Tests 215
Table 91: Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium
TB Test 216
Table 92: SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For
PhenoFluor 217
Table 93: Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 218
Table 94: MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
219
Table 95: NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
220
Table 96: Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis 221
Table 97: Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4
POC Test 222
Table 98: One Lambda Enters Into Co-Marketing Agreement With CellTrend 223
Table 99: Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For
ALK Cancer Biomarker 224
Table 100: Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 225
Table 101: Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG
Marker 226
Table 102: Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor
Cell Technology 227
Table 103: Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA 228
Table 104: Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For
LongRange PCR Kit 229
Table 105: Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo 230
Table 106: Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For
Pressure Cycling Technology 231
Table 107: LipoScience Enters Into Licensing Agreement With Cleveland Clinic 232
Table 108: GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact

Cyclotron And PET Tracer System 233
Table 109: NexDx Enters Into Licensing Agreement With University of California For Epigenetic
Biomarkers 234
Table 110: Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 235

1.2 List of Figures
Figure 1: In Vitro Diagnostics, Market Segmentation 17
Figure 2: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, 2004-2018 18
Figure 3: In Vitro Diagnostics Market, Saudi Arabia, Revenue Mix ($m), 2011 20
Figure 4: In Vitro Diagnostics Market, Saudi Arabia, Category Contribution (%), 2011 21
Figure 5: In Vitro Diagnostics Market, Saudi Arabia, Cross-Category Analysis, 2004-2018 22
Figure 6: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 24
Figure 7: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, Forecast,
2011-2018 26
Figure 8: In Vitro Diagnostics, Saudi Arabia, Company Share (%), 2011 28
Figure 9: Clinical Chemistry, Market Segmentation 30
Figure 10: Clinical Chemistry Market, Saudi Arabia, Revenue Mix ($m), 2011 31
Figure 11: Clinical Chemistry Market, Saudi Arabia, Segment Contribution (%), 2011 32
Figure 12: Clinical Chemistry, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 33
Figure 13: Clinical Chemistry, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 35
Figure 14: Clinical Chemisty Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Figure 15: Clinical Chemisty Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Figure 16: Urine Analysis, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 41
Figure 17: Urine Analysis, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 43
Figure 18: Clinical Chemistry, Saudi Arabia, Company Share (%), 2011 46
Figure 19: Genetic Testing, Market Segmentation 48
Figure 20: Genetic Testing Market, Saudi Arabia, Revenue Mix ($m), 2011 49
Figure 21: Genetic Testing Market, Saudi Arabia, Segment Contribution (%), 2011 50
Figure 22: Genetic Testing, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 51
Figure 23: Genetic Testing, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 53
Figure 24: Genetic Testing, Saudi Arabia, Company Share (%), 2011 56
Figure 25: Haematology Market, Market Segmentation 58
Figure 26: Haematology Market, Saudi Arabia, Revenue Mix ($m), 2011 59

Figure 27: Haematology Market, Saudi Arabia, Segment Contribution (%), 2011 60
Figure 28: Haematology, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 61
Figure 29: Haematology, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 63
Figure 30: Haematology Reagents, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 65
Figure 31: Haematology Reagents, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 67
Figure 32: Immunohaematology, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 69
Figure 33: Immunohaematology, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 71
Figure 34: Haemostasis, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 73
Figure 35: Haemostasis, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 75
Figure 36: Haematology Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Figure 37: Haematology Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Figure 38: Haematology Cell Counters, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Figure 39: Haematology Cell Counters, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Figure 40: Haematology, Saudi Arabia, Company Share (%), 2011 86
Figure 41: Histology and Cytology Market, Market Segmentation 88
Figure 42: Histology And Cytology Market, Saudi Arabia, Revenue Mix ($m), 2011 89
Figure 43: Histology And Cytology Market, Saudi Arabia, Segment Contribution (%), 2011 90
Figure 44: Histology And Cytology, Saudi Arabia, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 91
Figure 45: Histology And Cytology, Saudi Arabia, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 93
Figure 46: Histology And Cytology, Saudi Arabia, Company Share (%), 2011 96
Figure 47: Immuno Chemistry Market, Saudi Arabia, Revenue Mix ($m), 2011 98
Figure 48: Immuno Chemistry Market, Saudi Arabia, Segment Contribution (%), 2011 99
Figure 49: Immuno Chemistry, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 100
Figure 50: Immuno Chemistry, Saudi Arabia, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 102
Figure 51: Disease Specific Immunochemistry, Saudi Arabia, Revenue ($m) USD Constant, by

Figure 52: Disease Specific Immunochemistry, Saudi Arabia, Revenue ($m) USD Constant, by
Figure 53: Drugs of Abuse / Toxicology, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Figure 54: Drugs of Abuse / Toxicology, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Figure 55: Endocrinology Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 112
Figure 56: Endocrinology Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 114
Figure 57: Immunochemistry Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Figure 58: Immunochemistry Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Figure 59: Therapeutic Drug Monitoring, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Figure 60: Therapeutic Drug Monitoring, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Figure 61: Immunochemistry Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Figure 62: Immunochemistry Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-
Figure 63: Immuno Chemistry, Saudi Arabia, Company Share (%), 2011 129
Figure 64: Infectious Immunology, Market Segmentation 131
Figure 65: Infectious Immunology Market, Saudi Arabia, Revenue Mix ($m), 2011 132
Figure 66: Infectious Immunology Market, Saudi Arabia, Segment Contribution (%), 2011 133
Figure 67: Infectious Immunology, Saudi Arabia, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 134
Figure 68: Infectious Immunology, Saudi Arabia, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 136
Figure 69: Infectious Immunology Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by
Figure 70: Infectious Immunology Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by
Figure 71: Infectious Immunology, Saudi Arabia, Company Share (%), 2011 143
Figure 72: Microbiology Culture, Market Segmentation 145
Figure 73: Microbiology Culture Market, Saudi Arabia, Revenue Mix ($m), 2011 146
Figure 74: Microbiology Culture Market, Saudi Arabia, Segment Contribution (%), 2011 147
Figure 75: Microbiology Culture, Saudi Arabia, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 148
Figure 76: Microbiology Culture, Saudi Arabia, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 150

Figure 77: Microbiology Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 152
Figure 78: Microbiology Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 154
Figure 79: Microbiology Culture, Saudi Arabia, Company Share (%), 2011 157
Figure 80: F. Hoffmann-La Roche Ltd., Company Share (%),Saudi Arabia In Vitro Diagnostics
Market, 2011 159
Figure 81: Siemens Healthcare, Company Share (%),Saudi Arabia In Vitro Diagnostics Market,
2011 160
Figure 82: Abbott Laboratories, Company Share (%),Saudi Arabia In Vitro Diagnostics Market,
2011 161
Figure 83: Beckman Coulter, Inc., Company Share (%),Saudi Arabia In Vitro Diagnostics Market,
2011 162
Figure 84: bioMerieux S.A., Company Share (%),Saudi Arabia In Vitro Diagnostics Market, 2011
163
Figure 85: Becton, Dickinson and Company, Company Share (%),Saudi Arabia In Vitro
Diagnostics Market, 2011 164
Contact: sales@reportsandreports.com for more information.

Saudi Arabia In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (19)

Ähnlich wie Saudi Arabia In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Ähnlich wie Saudi Arabia In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture (20)

Saudi Arabia In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture